trial

Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)

NCTId NCT00156091
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 260 (actual)
Sponsored by Organon and Co
Primary completion 2007-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
260 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2005-04
Primary completion
2007-06
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
OlanzapineAsenapine

Sponsors

Organon and CoLead Sponsor

Sites

0 total

Linked catalysts

1
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Contro — primary completion2007-06

Facts & assertions

4 sourced
Enrollment
260
Phase
PHASE3
Primary Completion Date
2007-06
Status
COMPLETED
relationships
The graph out of here
drug
Olanzapine
drug
Asenapine
drug
lead_sponsor
Organon and Co
company
indication
Schizophrenia
indication
Schizophrenia
indication